Overview
Lobbying Costs
10,000€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
0.1 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Dolon
EU Transparency Register
723787246823-76 First registered on 09 Jun 2022
Goals / Remit
Dolon is a strategic market access consultancy. We work with pharmaceutical manufacturers to ensure effective treatments for rare and severe diseases are made accessible to the patients who need them.
Main EU files targeted
EU Orphan Medicinal Products Regulation (revision) and EU Paediatric Regulation
Website
-
People
Total lobbyists declared
1
Employment time Lobbyists 10% 1 Lobbyists (Full time equivalent)
0.1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
10,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount European Federation of Pharmaceutical Industries and Associations Orphan Medicinal Products regulation revision 0€ - 10,000€ Clients for current financial year
Clients list
Name European Federation of Pharmaceutical Industries and Associations Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
Meetings
Meetings
None declared